Motus GI Holdings, Inc. (MOTS)
| Market Cap | 7.00 -100.0% |
| Revenue (ttm) | 327.00K -47.9% |
| Net Income | -16.10M |
| EPS | -3.09 |
| Shares Out | 7.19M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1 |
| Open | 0.0001 |
| Previous Close | 0.0001 |
| Day's Range | 0.0001 - 0.0001 |
| 52-Week Range | n/a |
| Beta | 3.52 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | n/a |
About Motus GI Holdings
Motus GI Holdings, Inc. operates as a medical technology company in the United States. It develops Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during the colonoscopy and facilitates upper gastrointestinal endoscopy procedures. The company was formerly known as Eight-Ten Merger Corp. and changed its name to Motus GI Holdings, Inc. in November 2016. The company was founded in 2008 and is based in Fort Lauderdale, Florida. [Read more]
Financial Performance
In 2023, Motus GI Holdings's revenue was $319,000, a decrease of -46.11% compared to the previous year's $592,000. Losses were -$12.87 million, -30.81% less than in 2022.
Financial StatementsNews
Motus GI Holdings Proxy statement: Proxy Filing
Motus GI Holdings filed a proxy statement on June 26, 2024, providing details for shareholder voting and corporate governance matters.
Motus GI Holdings Proxy statement: Proxy Filing
Motus GI Holdings filed a proxy statement on June 14, 2024, providing details for shareholder voting and corporate governance matters.
Motus GI Holdings Quarterly report: Q1 2024
Motus GI Holdings has published its Q1 2024 quarterly earnings report on May 14, 2024.
Motus GI Holdings Earnings release: Q1 2024
Motus GI Holdings released its Q1 2024 earnings on May 14, 2024, summarizing the period's financial results.
Introducing Motus Protect: Unique Risk Management Solutions for Companies Dependent on Employee-Owned Vehicles
BOSTON--(BUSINESS WIRE)--Motus introduces Motus Protect: A Unique Risk Management Solutions for Companies Dependent on Employee-Owned Vehicles.
Motus GI Holdings files to sell 4.4M shares of common stock for holders
16:23 EDT Motus GI Holdings files to sell 4.4M shares of common stock for holders
Motus GI Holdings Registration statement: Registration Filing
Motus GI Holdings filed a registration statement on March 22, 2024, providing details about a securities offering with the SEC.
Motus GI Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
FORT LAUDERDALE, Fla., March 18, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc., (NASDAQ: MOTS) (“Motus GI” or the “Company”), a medical technology company focused on improving endoscopic outcomes a...
Motus GI Holdings Annual report: Q4 2023
Motus GI Holdings has published its Q4 2023 annual report on March 18, 2024.
Motus GI Holdings Earnings release: Q4 2023
Motus GI Holdings released its Q4 2023 earnings on March 18, 2024, summarizing the period's financial results.
EndoSound™ Inc., Appoints Medical Device Commercial Leader Scott Aldrich Jr as Chief Executive Officer
PORTLAND, Ore.--(BUSINESS WIRE)--EndoSound™ Inc., a pioneering medical technology company dedicated to advancing patient care, is pleased to announce the appointment of Scott Aldrich Jr as Chief Execu...
Motus GI Holdings announces exercise of warrants for $2.7M gross proceeds
Motus GI Holdings has entered into a definitive agreement for the immediate exercise of an outstanding Series B common stock purchase warrant held by an institutional investor to purchase an…
Motus GI Holdings, Inc. Announces Exercise of Warrants for $2.7 Million Gross Proceeds
FORT LAUDERDALE, Fla., Feb. 22, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus” or “the Company”), a medical technology company focused on improving endoscopic outcomes and ...
Motus GI Holdings granted patent for Pure-Vu System feature
Motus GI Holdings announced that the United States Patent and Trademark Office has issued the Company a new patent titled, “Colon Cleaning System with Automatic Self-Purging Feature.” The new patent…
Motus GI Holdings Granted a U.S. Patent for a Key Feature Embodied by the Pure-Vu® System to Avoid Clogging in Cleansing the GI Tract
FORT LAUDERDALE, Fla., Feb. 21, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the “Company”) (NASDAQ: MOTS), a medical technology company focused on improving endoscopic outcomes and experiences,...
Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders
FORT LAUDERDALE, Fla., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the Company”) (NASDAQ: MOTS), today announced that its special meeting of stockholders held on February 16, 2024 (the...
Motus GI Holdings Proxy statement: Proxy Filing
Motus GI Holdings filed a proxy statement on February 16, 2024, providing details for shareholder voting and corporate governance matters.
Motus GI Holdings publishes results from European study of Pure-Vu system
Motus GI Holdings announced the publication of positive data from a study of the second generation Pure-Vu System in a manuscript titled, “An intraprocedural bowel cleansing system for difficult-to-pr...
Motus GI Holdings Publishes Positive Results from a European Study of the Second Generation Pure-Vu System in Improving Visualization for Colonoscopy in Patients with a History of Poor Bowel Preparation
FORT LAUDERDALE, Fla., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus GI” or “the Company”), a medical technology company focused on improving endoscopic outcomes a...
Motus GI Holdings Proxy statement: Proxy Filing
Motus GI Holdings filed a proxy statement on January 24, 2024, providing details for shareholder voting and corporate governance matters.
Motus GI Holdings Proxy statement: Proxy Filing
Motus GI Holdings filed a proxy statement on January 12, 2024, providing details for shareholder voting and corporate governance matters.
Motus GI Holdings, Inc. Announces Pricing of $5.0 Million Public Offering
FORT LAUDERDALE, Fla., Dec. 18, 2023 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (Nasdaq: MOTS, or “Motus GI” or “the Company”), a medical technology company focused on improving endoscopic outcomes a...
Motus GI Holdings Registration statement: Registration Filing
Motus GI Holdings filed a registration statement on December 14, 2023, providing details about a securities offering with the SEC.
Motus GI Holdings Registration statement: Registration Filing
Motus GI Holdings filed a registration statement on December 11, 2023, providing details about a securities offering with the SEC.
Motus GI Holdings Registration statement: Registration Filing
Motus GI Holdings filed a registration statement on November 30, 2023, providing details about a securities offering with the SEC.